# OXYBUTYNIN CHLORIDE
> **ANDA211062** · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2019-02-06
## Drug
- **FDA Application Number:** ANDA211062
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYBUTYNIN CHLORIDE
- **Generic name:** Oxybutynin Chloride
- **Active ingredients:** OXYBUTYNIN CHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HIBROW HLTHCARE
- **First approval:** 2019-02-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211062)
---
*AI Analytics · CC0 1.0*